Vivo Capital - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $79,896.78 +4.51%
Ethereum $3,207.87 +5.11%
BNB $639.64 +2.29%
Optimism $1.69 +2.63%
Arbitrum $0.65 +5.60%
Solana $206.54 +2.26%
Polygon $0.41 +5.26%
Cosmos $5.27 +10.71%
Avalanche $31.97 +8.82%

Bitcoin $79,896.78 +4.51%
Ethereum $3,207.87 +5.11%
BNB $639.64 +2.29%
Optimism $1.69 +2.63%
Arbitrum $0.65 +5.60%
Solana $206.54 +2.26%
Polygon $0.41 +5.26%
Cosmos $5.27 +10.71%
Avalanche $31.97 +8.82%

Vivo Capital

company

Investments

Number of Investments

Number of Lead Investments

16

4

Vivo Capital has made 16 investments. Their most recent investment was on Nov 29, 2022, when Rgenta Therapeutics, Inc raised

Date	Company Name	Round	Money Raised	Industry	Lead Investor
Nov 29, 2022	Rgenta Therapeutics	Series A	—	Biotechnology	—
Oct 27, 2022	Neocis	Series D	—	Dental	—
Jul 6, 2022	Tebra	Series B	—	Electronic Health Record (EHR)	—
May 25, 2021	Rgenta Therapeutics	Seed	—	Biotechnology	—
May 6, 2021	Aerobiotix	Series Unknown	—	Health Care	Yes
Jan 5, 2021	Terns Pharmaceuticals	Series C	—	Biotechnology	—
Oct 8, 2020	Neocis	Series D	—	Dental	—
Sep 4, 2019	Passage Bio	Series B	—	Biotechnology	—
Feb 15, 2019	Passage Bio	Series A	—	Biotechnology	—
Oct 30, 2018	Terns Pharmaceuticals	Series B	—	Biotechnology	Yes
Nov 27, 2017	Medeor Therapeutics	Series B	—	Biotechnology	—
Aug 3, 2017	Amyris	Post-IPO Equity	—	Biotechnology	Yes
Apr 13, 2016	Kala Pharmaceuticals	Series C	—	Biotechnology	—
Nov 6, 2013	Ocera Therapeutics	Post-IPO Equity	—	Biopharma	—
Apr 15, 2011	Eiger BioPharmaceuticals	Series A	—	Biotechnology	—
Feb 25, 2009	Eiger BioPharmaceuticals	Series A	—	Biotechnology	Yes